Khiron Life Sciences Corp.

  • instagram
  • LinkedIn
language
English Español Português Deutsch

A GLOBAL MEDICAL CANNABIS COMPANY

IMPROVING THE QUALITY OF PEOPLES' LIVES

TSXV: KHRN | OTCQX: KHRNF | FRANKFURT: A2JMXC

6
Countries:
 SELLING IN COLOMBIA, PERU, GERMANY, UK, BRAZIL AND TARGETING MEXICO FOR 2022
>50,000
Medical cannabis prescriptions filled year-to-date
>50%
MEDICAL CANNABIS REVENUES GENERATED IN EUROPE IN Q1 2022
>70%
Gross margin on medical cannabis sales in 2021
>60%
Retention Rate AT KHIRON'S ZERENIA CLINIC PATIENTS GLOBALLY
>80%
MEDICAL CANNABIS SALES THROUGH INSURANCE IN COLOMBIA

AWT $KHRNF Khiron Life Sciences Update Alvaro Torres CEO

Khiron at Benzinga Cannabis Insider

Patients Stories

AWT Mystery Interview #10 Reveal $KHRNF Khiron Life Sciences CEO Alvaro F Torres Co-Founder & CEO

Vicente Fox on BNN Bloomberg

CannaWeek: Ep 73 - Alvaro Torres, Khiron Life Sciences

OUR
BUSINESS UNITS

khiron
Health Services
khiron
Med

GLOBAL
EXPANSION

Khiron is well-positioned to take advantage of the emerging global cannabis opportunity.

OUR
PRODUCTION FACILITY

Cultivation: Upwards 0f 9 tonnes of dry flower. Fully licensed for commercial THC and CBD cultivation, extraction & sales in Colombia.

  • Total area of 20 Ha. Current cultivation area of 80,000 sq. ft.
  • ~1 MW Solar Park with capacity to reduce energy consumption by 40%

Our
Laboratory

  • State-of-the-art, 14,000 sq.ft. GMP-compliant post-harvest facility in Doima, Colombia (157 km. West of Bogota)
  • Extraction: Up to 3 tonnes of full-spectrum extract, with capacity to expand within the building

Leadership

KHIRON LIFE SCIENCES is led by a multidisciplinary and multicultural team with a unique understanding of various industries across Latin America and Europe

View Management Team View Board of Directors

Investor
Contact

T: 1 (647) 556-5750
investors@khiron.ca

Have a business-related question about KHRN? Or just general inquiries? Send us a message and we'll be happy to help.

Contact Us

Investor Email Alerts